Literature DB >> 25627729

Medical cannabis: time for clear thinking.

David G Penington1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25627729     DOI： 10.5694/mja14.01573

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  2 in total

1.  Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Authors:  Antony J Mersiades; Annette Tognela; Paul S Haber; Martin Stockler; Nicholas Lintzeris; John Simes; Iain McGregor; Ian Olver; David J Allsop; Craig Gedye; Adrienne C Kirby; Rachael L Morton; Peter Fox; Stephen Clarke; Karen Briscoe; Morteza Aghmesheh; Nicole Wong; Anna Walsh; Carmel Hahn; Peter Grimison
Journal:  BMJ Open       Date:  2018-09-12       Impact factor: 2.692

2.  Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience.

Authors:  Jennifer H Martin; Courtney Hill; Anna Walsh; Daryl Efron; Kaitlyn Taylor; Michael Kennedy; Rachel Galettis; Paul Lightfoot; Julie Hanson; Helen Irving; Meera Agar; Judith Lacey
Journal:  Trials       Date:  2020-11-17       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.